Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260669 (US9533985, 57) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260666 (US9533985, 54) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260671 (US9533985, 59) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260683 (US9533985, 71) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260681 (US9533985, 69) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260667 (US9533985, 55) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260654 (US9533985, 42) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260660 (US9533985, 48) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 54 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260674 (US9533985, 62) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260680 (US9533985, 68) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260653 (US9533985, 41) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260651 (US9533985, 39) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260673 (US9533985, 61) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260689 (US9533985, 77) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260668 (US9533985, 56) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260656 (US9533985, 44) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260662 (US9533985, 50) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 180 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260658 (US9533985, 46) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260679 (US9533985, 67) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 210 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM65394 (US9533985, 159 | US9533985, 40) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 210 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260655 (US9533985, 43) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 220 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260682 (US9533985, 70) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 270 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260678 (US9533985, 66) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 280 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260687 (US9533985, 75) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 310 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260661 (US9533985, 49) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 330 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260659 (US9533985, 47) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 340 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260690 (US9533985, 78) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 370 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260684 (US9533985, 72) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 400 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260670 (US9533985, 58) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 410 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260685 (US9533985, 73) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 410 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260677 (US9533985, 65) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 420 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260675 (US9533985, 63) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 480 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM65383 (BDBM260657 | US9533985, 157) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 500 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260686 (US9533985, 74) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 520 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM65398 (BDBM260664 | US9533985, 177) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM65399 (US9533985, 178 | US9533985, 53) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 740 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260688 (US9533985, 76) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 910 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260672 (US9533985, 60) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260663 (US9533985, 51) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260676 (US9533985, 64) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair |